Stryker Revenue 2006-2018 | SYK

Current and historical revenue for Stryker (SYK) from 2006 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities. Stryker revenue for the twelve months ending June 30, 2018 was $13.040B. Stryker revenue for the three months ending June 30, 2018 was $3.322B, representing a 10.29% increase from the same quarter last year.
Stryker Annual Revenue
(Millions of US $)
2017 $12,444
2016 $11,325
2015 $9,946
2014 $9,675
2013 $9,021
2012 $8,657
2011 $8,307
2010 $7,320
2009 $6,723
2008 $6,718
2007 $6,001
2006 $5,147
2005 $4,609
Stryker Quarterly Revenue
(Millions of US $)
Q2 2018 $3,322
Q1 2018 $3,241
Q4 2017 $3,471
Q3 2017 $3,006
Q2 2017 $3,012
Q1 2017 $2,955
Q4 2016 $3,157
Q3 2016 $2,833
Q2 2016 $2,840
Q1 2016 $2,495
Q4 2015 $2,715
Q3 2015 $2,420
Q2 2015 $2,432
Q1 2015 $2,379
Q4 2014 $2,618
Q3 2014 $2,389
Q2 2014 $2,363
Q1 2014 $2,305
Q4 2013 $2,468
Q3 2013 $2,151
Q2 2013 $2,212
Q1 2013 $2,190
Q4 2012 $2,338
Q3 2012 $2,052
Q2 2012 $2,106
Q1 2012 $2,161
Q4 2011 $2,215
Q3 2011 $2,031
Q2 2011 $2,046
Q1 2011 $2,015
Q4 2010 $1,995
Q3 2010 $1,768
Q2 2010 $1,758
Q1 2010 $1,799
Q4 2009 $1,834
Q3 2009 $1,653
Q2 2009 $1,634
Q1 2009 $1,601
Q4 2008 $1,718
Q3 2008 $1,653
Q2 2008 $1,713
Q1 2008 $1,634
Q4 2007 $1,658
Q3 2007 $1,453
Q2 2007 $1,464
Q1 2007 $1,426
Q4 2006 $1,333
Q3 2006 $1,231
Q2 2006 $1,262
Q1 2006 $1,321
Q4 2005 $1,016
Q3 2005 $1,172
Q2 2005 $1,219
Q1 2005 $1,203
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $63.571B $12.444B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.465B 18.95
Abbott Laboratories (ABT) United States $113.540B 23.79
Boston Scientific (BSX) United States $47.586B 24.75
Baxter (BAX) United States $38.489B 26.20
Zimmer Biomet Holdings (ZBH) United States $25.204B 16.19
Smith & Nephew SNATS (SNN) United Kingdom $15.640B 0.00
ResMed (RMD) United States $15.244B 30.25
Perrigo (PRGO) Ireland $9.983B 14.17
Bio-Rad Laboratories (BIO) United States $9.444B 60.64
Canopy Growth (CGC) Canada $7.445B 0.00
Hill-Rom Holdings (HRC) United States $6.341B 21.51
ICU Medical (ICUI) United States $6.026B 40.83
Haemonetics (HAE) United States $5.351B 48.83
Insulet (PODD) United States $5.209B 0.00
Agios Pharmaceuticals (AGIO) United States $4.408B 0.00
Neogen (NEOG) United States $4.360B 69.38
Hutchison China MediTech (HCM) China $3.903B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.778B 0.00
NuVasive (NUVA) United States $3.598B 34.13
National Vision Holdings (EYE) United States $3.054B 67.43
Quidel (QDEL) United States $2.769B 56.74
Phibro Animal Health (PAHC) United States $1.990B 29.55
NxStage Medical (NXTM) United States $1.846B 0.00
Cardiovascular Systems (CSII) United States $1.249B 751.20
Eagle Pharmaceuticals (EGRX) United States $1.176B 34.73
VAREX IMAGING (VREX) United States $1.130B 18.47
AtriCure (ATRC) United States $1.099B 0.00
Omeros (OMER) United States $1.016B 0.00
OraSure Technologies (OSUR) United States $1.001B 65.44
Owens & Minor (OMI) United States $0.990B 10.59
Surmodics (SRDX) United States $0.981B 118.47
TG Therapeutics (TGTX) United States $0.957B 0.00
Cerus (CERS) United States $0.922B 0.00
PetIQ (PETQ) United States $0.847B 29.00
MacroGenics (MGNX) United States $0.845B 0.00
LeMaitre Vascular (LMAT) United States $0.716B 34.34
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.574B 0.00
Evolus (EOLS) United States $0.527B 0.00
Lantheus Holdings (LNTH) United States $0.515B 16.01
NanoString Technologies (NSTG) United States $0.417B 0.00
Cytosorbents (CTSO) United States $0.363B 0.00
BioLife Solutions (BLFS) United States $0.325B 0.00
Utah Medical Products (UTMD) United States $0.324B 20.86
Quanterix (QTRX) United States $0.324B 0.00
Surface Oncology (SURF) United States $0.279B 0.00
Rockwell Medical (RMTI) United States $0.216B 0.00
Chimerix (CMRX) United States $0.195B 0.00
Fonar (FONR) United States $0.170B 10.34
Chembio Diagnostics (CEMI) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.119B 0.00
Female Health (VERU) United States $0.115B 0.00
United-Guardian (UG) United States $0.086B 18.83
Trinity Biotech (TRIB) Ireland $0.085B 25.25
Oramed Pharmaceuticals (ORMP) Israel $0.082B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.064B 0.00
CAS Medical Systems (CASM) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Capricor Therapeutics (CAPR) United States $0.032B 0.00
Akers Biosciences Inc (AKER) United States $0.025B 0.00
Senestech (SNES) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00